Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: BiBBInstruments’ CEO comments on the results of a clinical case series for EndoDrill GI in the U.S.

BiBBInstruments

Henry Ford St. John Hospital & Medical Center in Detroit has reported a U.S. case series using the cancer diagnostics company BiBBInstruments’ powered biopsy device, EndoDrill GI. The evaluation, presented at the 4th Annual Michigan GI Society Conference, demonstrated the instrument’s excellent ability to obtain diagnostic tissue samples from both the liver and pancreas. We contacted CEO Fredrik Lindblad for a comment on the results.

Read the full interview at biostock.se:
 
https://biostock.se/en/2025/08/bibbinstruments-ceo-comments-on-the-results-of-a-clinical-case-series-for-endodrill-gi-in-the-u-s/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.